dihydroergotamine has been researched along with amitriptyline in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamblin, MW; Monsma, FJ; Shen, Y; Sibley, DR; Ward, RP | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Banaszkiewicz, W; Grzymislawska, I; Mrozikiewica, A | 1 |
| Deliganis, AV; Peroutka, SJ | 1 |
| Bousser, MG; Massiou, H | 2 |
| Barone, P; Bonuso, S; Di Stasio, E; Steardo, L | 1 |
| Titus, F | 1 |
| Bagcivan, I; Gursoy, S; Ozdemir, E | 1 |
| Patterson-Gentile, C; Szperka, CL | 1 |
2 review(s) available for dihydroergotamine and amitriptyline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The Changing Landscape of Pediatric Migraine Therapy: A Review.
Topics: Adolescent; Adrenergic beta-Antagonists; Amitriptyline; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Calcium Channel Blockers; Child; Cognitive Behavioral Therapy; Dihydroergotamine; Dopamine Antagonists; Fluid Therapy; Glucocorticoids; Headache Disorders, Secondary; Humans; Magnesium; Migraine Disorders; Nerve Block; Topiramate; Tryptamines; Valproic Acid | 2018 |
1 trial(s) available for dihydroergotamine and amitriptyline
| Article | Year |
|---|---|
Timed-release dihydroergotamine in the prophylaxis of mixed headache. A study versus amitriptyline.
Topics: Adolescent; Adult; Amitriptyline; Clinical Trials as Topic; Delayed-Action Preparations; Dihydroergotamine; Female; Headache; Humans; Male; Middle Aged; Random Allocation | 1983 |
9 other study(ies) available for dihydroergotamine and amitriptyline
| Article | Year |
|---|---|
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain Chemistry; Cell Line; Cloning, Molecular; DNA; GTP-Binding Proteins; Lysergic Acid Diethylamide; Molecular Sequence Data; Polymerase Chain Reaction; Psychotropic Drugs; Rats; Receptors, Serotonin; RNA; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection | 1993 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Influence of some antidepressant drugs on the circulatory system: II. Action of amitriptyline and nortriptyline on basic circulatory parameters.
Topics: Amitriptyline; Animals; Atropine; Cats; Dihydroergotamine; Hemodynamics; In Vitro Techniques; Muscle, Smooth; Myocardial Contraction; Norepinephrine; Nortriptyline; Propranolol; Quaternary Ammonium Compounds; Rabbits; Respiration | 1975 |
5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy.
Topics: Adenylyl Cyclase Inhibitors; Amitriptyline; Animals; Cattle; Caudate Nucleus; Dihydroergotamine; Ergotamine; Indoles; Kinetics; Methysergide; Migraine Disorders; Radioligand Assay; Receptors, Serotonin; Serotonin; Sulfonamides; Sumatriptan; Vasoconstrictor Agents; Verapamil | 1991 |
[Antimigrainous agents. General considerations and treatment of the crisis].
Topics: Acupuncture Therapy; Amitriptyline; Analgesics; Anti-Anxiety Agents; Anti-Inflammatory Agents; Antiemetics; Caffeine; Dihydroergotamine; Ergotamine; Ergotamines; Humans; Migraine Disorders | 1986 |
[Antimigrainous agents used in maintenance treatment].
Topics: Adrenergic beta-Antagonists; Amitriptyline; Aspirin; Benzoxepins; Calcium Channel Blockers; Cinnarizine; Clonidine; Dihydroergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Pizotyline; Propranolol | 1986 |
[The treatment of migraine].
Topics: Adrenergic beta-Antagonists; Amitriptyline; Calcium Channel Blockers; Dihydroergotamine; Ergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Nicardipine; Nimodipine; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents | 1997 |
New "triptans" and other drugs for migraine.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents | 1998 |
The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats.
Topics: Amitriptyline; Analgesia; Analgesics; Animals; Cyclohexanols; Dihydroergotamine; Drug Tolerance; Male; Morphine; Pain Measurement; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 2012 |